S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Modern Day Options Trading For Beginners! (Ad)pixel
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Urgent Warning (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Modern Day Options Trading For Beginners! (Ad)pixel
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Urgent Warning (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Modern Day Options Trading For Beginners! (Ad)pixel
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Urgent Warning (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Modern Day Options Trading For Beginners! (Ad)pixel
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Urgent Warning (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:ONTX

Onconova Therapeutics - ONTX Short Interest Ratio & Short Volume

$0.73
+0.01 (+1.39%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.69
$0.76
50-Day Range
$0.69
$1.42
52-Week Range
$0.62
$2.04
Volume
41,073 shs
Average Volume
233,185 shs
Market Capitalization
$15.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Onconova Therapeutics Short Interest Data

Current Short Volume
32,400 shares
Previous Short Volume
19,200 shares
Change Vs. Previous Month
+68.75%
Dollar Volume Sold Short
$26,276.40
Short Interest Ratio / Days to Cover
0.2
Last Record Date
February 28, 2023
Outstanding Shares
20,900,000 shares
Percentage of Shares Shorted
0.16%
Today's Trading Volume
41,073 shares
Average Trading Volume
233,185 shares
Today's Volume Vs. Average
-82.39%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Onconova Therapeutics ?

Sign up to receive the latest short interest report for Onconova Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ONTX Short Interest Over Time

ONTX Days to Cover Over Time

ONTX Percentage of Float Shorted Over Time

Onconova Therapeutics (NASDAQ:ONTX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/202332,400 shares $26,276.40 +68.8%N/A0.2 $0.81
2/15/202319,200 shares $17,362.56 +64.1%N/A0.1 $0.90
1/31/202311,700 shares $14,625.00 +54.0%N/A0.1 $1.25
1/15/20237,600 shares $6,687.25 -12.6%N/A0.1 $0.88
12/30/20228,700 shares $5,617.59 +19.2%N/A0.1 $0.65
12/15/20227,300 shares $5,158.55 -42.1%N/A0.1 $0.71
11/30/202212,600 shares $10,521.00 -23.2%N/A0.2 $0.84
11/15/202216,400 shares $13,776.00 -58.8%N/A0.2 $0.84
10/31/202239,800 shares $28,656.00 +186.3%N/A0.6 $0.72
10/15/202213,900 shares $9,727.22 -9.7%N/A0.1 $0.70
9/30/202215,400 shares $13,567.40 -16.8%N/A0.2 $0.88
9/15/202218,500 shares $21,645.00 -33.5%N/A0.2 $1.17
8/31/202227,800 shares $33,221.00 +86.6%N/A0.3 $1.20
8/15/202214,900 shares $18,923.00 -12.9%N/A0.1 $1.27
7/31/202217,100 shares $20,596.95 -46.2%N/A0.1 $1.20
7/15/202231,800 shares $40,386.00 -14.8%N/A0.3 $1.27
6/30/202237,300 shares $49,236.00 +103.8%N/A0.4 $1.32
6/15/202218,300 shares $21,777.00 -72.2%N/A0.2 $1.19
5/31/202265,800 shares $77,644.00 -25.8%N/A0.6 $1.18
5/15/202288,700 shares $95,796.00 +26.5%N/A0.7 $1.08
4/30/202270,100 shares $97,439.00 +33.5%N/A0.5 $1.39
4/15/202252,500 shares $84,525.00 -23.3%N/A0.3 $1.61
3/31/202268,400 shares $125,856.00 +15.9%N/A0.4 $1.84
3/15/202259,000 shares $88,500.00 -65.7%N/A0.3 $1.50
2/28/2022171,900 shares $278,478.00 -18.1%N/A0.7 $1.62
2/15/2022209,900 shares $358,929.00 +42.7%N/A0.8 $1.71
1/31/2022147,100 shares $286,845.00 -31.3%N/A0.5 $1.95
1/15/2022214,200 shares $475,524.00 +112.1%N/A0.6 $2.22
12/31/2021101,000 shares $257,550.00 -17.0%N/A0.3 $2.55
12/15/2021121,700 shares $340,760.00 -38.4%N/A0.2 $2.80
11/30/2021197,400 shares $592,200.00 -43.4%N/A0.1 $3.00
11/15/2021348,500 shares $1.23 million -20.5%N/A0.2 $3.53
10/29/2021438,200 shares $1.52 million -52.6%N/A0.2 $3.46
10/15/2021923,500 shares $3.39 million -12.9%N/A0.5 $3.67
9/30/20211,060,000 shares $4.06 million +90.1%N/A0.6 $3.83
9/15/2021557,600 shares $2.70 million -16.2%3.8%0.3 $4.84
8/31/2021665,200 shares $3.55 million -7.8%4.5%1.8 $5.33
8/13/2021721,300 shares $3.58 million +12.3%4.9%1.1 $4.96
7/30/2021642,600 shares $3.19 million -18.7%4.3%0.5 $4.97
7/15/2021790,100 shares $4.23 million +9.8%5.3%0.6 $5.35













ONTX Short Interest - Frequently Asked Questions

What is Onconova Therapeutics' current short interest?

Short interest is the volume of Onconova Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 32,400 shares of ONTX short. Learn More on Onconova Therapeutics' current short interest.

Which institutional investors are shorting Onconova Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Onconova Therapeutics: Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Onconova Therapeutics' short interest increasing or decreasing?

Onconova Therapeutics saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 32,400 shares, an increase of 68.8% from the previous total of 19,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Onconova Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Onconova Therapeutics: Cocrystal Pharma, Inc. (0.05%), Regulus Therapeutics Inc. (1.25%), CNS Pharmaceuticals, Inc. (1.56%), Lexaria Bioscience Corp. (6.75%), eFFECTOR Therapeutics, Inc. (0.25%), Addex Therapeutics Ltd (2.63%), Cellectar Biosciences, Inc. (0.15%), Applied Molecular Transport Inc. (0.91%), Humanigen, Inc. (6.98%), and Angion Biomedica Corp. (0.46%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

What does it mean to sell short Onconova Therapeutics stock?

Short selling ONTX is an investing strategy that aims to generate trading profit from Onconova Therapeutics as its price is falling. ONTX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Onconova Therapeutics?

A short squeeze for Onconova Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONTX, which in turn drives the price of the stock up even further.

How often is Onconova Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONTX, twice per month. The most recent reporting period available is February, 28 2023.



This page (NASDAQ:ONTX) was last updated on 3/25/2023 by MarketBeat.com Staff